Unusual 11 Mid-Day Movers 2/17: PACR, PERY, RZ, CYCC, UCTT Higher; NVMI, RNN, RICK, PSID Lower
Up)
Pacer International Inc. (NASDAQ: PACR) 20.5% HIGHER; reports Q4 EPS of $0.29, which may not compare to the analyst estimate of ($0.04), and a loss of $1.83 for Q408. Revenue for the quarter was $420.2 million, which compares to the estimate of $368.79 million.
Perry Ellis (Nasdaq: PERY) 17.9% HIGHER; sees FY10 EPS at or above the previously issued range of $0.80-$0.95. The Street is looking for FY10 EPS of $0.95. Sees FY11 EPS of $1.25-$1.40 on sales of $770-$790 million. The Street is currently looking for FY11 EPS and sales of $1.25 and $788.4 million, respectively.
Raser Technologies, Inc. (NYSE: RZ) 17.7% HIGHER; announced today that the U.S. Treasury has approved its renewable energy grant application for the Company’s Thermo No. 1 geothermal power plant. The grant is provided by the U.S. Treasury Department under the Section 1603 renewable energy grant program created by the American Recovery and Reinvestment Act of 2009. Raser should receive the funds within five business days.
Nova Measuring Instruments Ltd. (Nasdaq: NVMI) 16.4% LOWER; reports Q4 EPS of $0.15, ex-items, compared to a loss of $0.22 in the same quarter last year. Revenue for the quarter was $15.2 million, versus $11.39 million in Q408. Sees FY10 sales of $58-$63 million and net profitability of 10%-14%.
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) 15% HIGHER; today announced that a newly published study demonstrates that the company's seliciclib (CYC202 or R-roscovitine), an orally available inhibitor of multiple cyclin-dependent kinases, reversed resistance to the aromatase inhibitor letrozole (Femara) and killed hormone receptor positive breast cancer cells that had become insensitive to the effects of letrozole. The new study was published in the current edition of Clinical Cancer Research, a journal of the American Association for Cancer Research. Seliciclib is currently in Phase 2 clinical trials for non-small cell lung cancer and nasopharyngeal cancer. Click here for the full report.
Ultra Clean Holdings Inc. (Nasdaq: UCTT) 14.3% HIGHER; reports Q4 EPS of $0.09, ex-items. The company reported a GAAP loss of $2.45 in Q409. Revenue for the quarter was $72.8 million, which compares to the $47.07 million reported in the same quarter last year. Sees Q1 EPS of $0.10-$0.14. Sees Q1 sales of $82-$87 million.
Rexahn Pharmaceuticals, Inc. (AMEX: RNN) 13.9% LOWER; today provided guidance on its key pipeline, scientific and business goals for 2010. Click here to see details.
Lionsbridge Technologies (Nasdaq: LIOX) 13.1% HIGHER; not hearing any news today. The stock is continuing higher today after a pause yesterday. The stock rose everyday last week, adding about 30% to the stock price. Volume is heavy today. Some technicians may be buying the stock as the price approaches what seems to be an area of resistance around $3.40.
Rick's Cabaret International Inc. (Nasdaq: RICK) 13.8% LOWER; reports Q1 EPS of $0.09, 4 cents lower than the analyst estimate of $0.13. Revenue for the quarter was $20 million, which compares to the estimate of $19.32 million. Same store sales rose 14.5%. Also announced that it will acquire all of the outstanding shares of VCG Holding to form the largest publicly traded operator of upscale gentlemen's clubs in North America.
PositiveID Corporation (NASDAQ: PSID) 9.4% LOWER; announced today that it has acquired intellectual property rights and assets of Easy Check Medical Diagnostics, LLC, to expand its portfolio of non-invasive glucose-level testing products and diabetes management tools under development.
Photronics (NASDAQ: PLAB) 8% LOWER; reports Q1 adj-EPS of $0.01, 5 cents better than the analyst estimate of ($0.04). Revenue for the quarter was $98.2 million, which compares to the estimate of $94.67 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Perry Ellis (Nasdaq: PERY) 17.9% HIGHER; sees FY10 EPS at or above the previously issued range of $0.80-$0.95. The Street is looking for FY10 EPS of $0.95. Sees FY11 EPS of $1.25-$1.40 on sales of $770-$790 million. The Street is currently looking for FY11 EPS and sales of $1.25 and $788.4 million, respectively.
Raser Technologies, Inc. (NYSE: RZ) 17.7% HIGHER; announced today that the U.S. Treasury has approved its renewable energy grant application for the Company’s Thermo No. 1 geothermal power plant. The grant is provided by the U.S. Treasury Department under the Section 1603 renewable energy grant program created by the American Recovery and Reinvestment Act of 2009. Raser should receive the funds within five business days.
Nova Measuring Instruments Ltd. (Nasdaq: NVMI) 16.4% LOWER; reports Q4 EPS of $0.15, ex-items, compared to a loss of $0.22 in the same quarter last year. Revenue for the quarter was $15.2 million, versus $11.39 million in Q408. Sees FY10 sales of $58-$63 million and net profitability of 10%-14%.
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) 15% HIGHER; today announced that a newly published study demonstrates that the company's seliciclib (CYC202 or R-roscovitine), an orally available inhibitor of multiple cyclin-dependent kinases, reversed resistance to the aromatase inhibitor letrozole (Femara) and killed hormone receptor positive breast cancer cells that had become insensitive to the effects of letrozole. The new study was published in the current edition of Clinical Cancer Research, a journal of the American Association for Cancer Research. Seliciclib is currently in Phase 2 clinical trials for non-small cell lung cancer and nasopharyngeal cancer. Click here for the full report.
Ultra Clean Holdings Inc. (Nasdaq: UCTT) 14.3% HIGHER; reports Q4 EPS of $0.09, ex-items. The company reported a GAAP loss of $2.45 in Q409. Revenue for the quarter was $72.8 million, which compares to the $47.07 million reported in the same quarter last year. Sees Q1 EPS of $0.10-$0.14. Sees Q1 sales of $82-$87 million.
Rexahn Pharmaceuticals, Inc. (AMEX: RNN) 13.9% LOWER; today provided guidance on its key pipeline, scientific and business goals for 2010. Click here to see details.
Lionsbridge Technologies (Nasdaq: LIOX) 13.1% HIGHER; not hearing any news today. The stock is continuing higher today after a pause yesterday. The stock rose everyday last week, adding about 30% to the stock price. Volume is heavy today. Some technicians may be buying the stock as the price approaches what seems to be an area of resistance around $3.40.
Rick's Cabaret International Inc. (Nasdaq: RICK) 13.8% LOWER; reports Q1 EPS of $0.09, 4 cents lower than the analyst estimate of $0.13. Revenue for the quarter was $20 million, which compares to the estimate of $19.32 million. Same store sales rose 14.5%. Also announced that it will acquire all of the outstanding shares of VCG Holding to form the largest publicly traded operator of upscale gentlemen's clubs in North America.
PositiveID Corporation (NASDAQ: PSID) 9.4% LOWER; announced today that it has acquired intellectual property rights and assets of Easy Check Medical Diagnostics, LLC, to expand its portfolio of non-invasive glucose-level testing products and diabetes management tools under development.
Photronics (NASDAQ: PLAB) 8% LOWER; reports Q1 adj-EPS of $0.01, 5 cents better than the analyst estimate of ($0.04). Revenue for the quarter was $98.2 million, which compares to the estimate of $94.67 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
You May Also Be Interested In
- Morning Movers 05/25: (GNOM) (UPI) (EJ) Higher; (DCTH) (TLB) (GENE) Lower
- Notable Mergers and Acquisitions of the Day 05/23: (MON) (STX) (ORCL)
- Streetinsider.com's Hot Lunchtime Reads 05/25: (HAS) (ADP) (EMC) (PAY)
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
